Myriad Genetics Inc (MYGN)

31.15 +0.28  +0.91% NASDAQ Jul 28, 12:53 USD
View Full Chart
Price Chart
View All MYGN News

News

View All Events

Events

Date Type Description
08/13/2021 Earnings Results Q4 2021 Earnings Results
08/13/2021 16:30 EST Earnings Calls Q4 2021 Earnings Call
05/04/2021 11:00 EST Earnings Calls Q3 2021 Earnings Call
05/03/2021 Earnings Results Q3 2021 Earnings Results
02/23/2021 Earnings Results Q2 2021 Earnings Results
02/23/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
12/04/2020 10:00 EST AGM 2020 Annual General Meeting
11/09/2020 Earnings Results Q1 2021 Earnings Results
11/09/2020 17:00 EST Earnings Calls Q1 2021 Earnings Call
08/13/2020 16:30 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm produces myRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Vectra DA, which predicts disease progression in rheumatoid arthritis to optimize drug treatment; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
  • URL: https://www.myriad.com
  • Investor Relations URL: https://myriad.com/investors/news-release/
  • HQ State/Province: Utah
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 13, 2021
  • Last Earnings Release: May. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
CCMMX Conestoga Mid Cap Investors 3.01%
PBE Invesco Dynamic Biotech & Genome ETF 2.99%
GNOM Global X Genomics & Biotechnology ETF 2.53%
PSCH Invesco S&P SmallCap Health Care ETF 1.97%
PMJPX PIMCO RAE US Small I-2 1.23%
AZSAX American Beacon Zebra Small Cap Eq A 1.12%
XBI SPDR® S&P Biotech ETF 0.73%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.